Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH3A1 | P30838 | 4/20 | 0.61 |
| ▸ | HTT | P42858 | 4/20 | 0.58 |
| ▸ | POLB | P06746 | 3/20 | 0.57 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1804076 | 0.84 | HTT (0.66) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL7100805 | 0.81 | ALDH3A1 (0.61) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL22462430 | 0.81 | ALDH3A1 (0.61) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL1070947 | 0.81 | ALDH3A1 (0.57) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL830432 | 0.81 | ALDH3A1 (0.57) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL5080750 | 0.79 | ALDH3A1 (0.55) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL21820015 | 0.78 | HTT (0.58) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL422055 | 0.78 | ALDH3A1 (0.77) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL23701654 | 0.77 | ALDH3A1 (0.56) | ALDH3A1HTTPOLBNOD1L3MBTL1 | |
| SCHEMBL17753678 | 0.77 | GAA (0.59) | ALDH3A1HTTPOLBNOD1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735799-A | Preparation method of carbon dioxide-based polycarbonate polyol | 福建久策气体股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-9789118-B2 | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof | NOVARTIS AG (CH) | 2017-10-17 | — | — | US | disclosed |
| EP-2598486-B1 | BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS | NOVARTIS AG (CH) | 2017-06-28 | — | — | EP | disclosed |
| US-20140171363-A1 | BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF | NOVARTIS AG (CH) | 2014-06-19 | — | — | US | disclosed |
| US-8697739-B2 | Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof | NOVARTIS AG (CH) | 2014-04-15 | — | — | US | disclosed |
| EP-2598486-A1 | BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS | Novartis AG (CH) | 2013-06-05 | — | — | EP | disclosed |
| US-20120028969-A1 | BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF | NOVARTIS AG (CH) | 2012-02-02 | — | — | US | disclosed |
| WO-2012013716-A1 | BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS | NOVARTIS AG (CH) | 2012-02-02 | — | — | WO | disclosed |
| EP-1446701-A1 | METHOD FOR IMPROVING SENSITOMETRIC RESPONSE OF PHOTOSENSITIVE IMAGING MEDIA EMPLOYING MICROCAPSULES | HSBC Bank U.S.A. (US) | 2004-08-18 | — | — | EP | disclosed |
| US-6638678-B2 | Method for improving sensitometric response of photosensitive imaging media employing microcapsules | HSBC BANK USA | 2003-10-28 | — | — | US | disclosed |
| WO-2003044601-A1 | METHOD FOR IMPROVING SENSITOMETRIC RESPONSE OF PHOTOSENSITIVE IMAGING MEDIA EMPLOYING MICROCAPSULES | HSBC BANK USA (US) | 2003-05-30 | — | — | WO | disclosed |
| US-20030096187-A1 | Method for improving sensitometric response of photosensitive imaging media employing microcapsules | HSBC BANK USA, AS TRUSTEE OF THE CYCOLOR, INC. 2003 TRUST U/A | 2003-05-22 | — | — | US | disclosed |
| US-6004540-A | SUNSCREEN AGENTS | SOCIETE L'OREAL S.A. (FR) | 1999-12-21 | — | — | US | disclosed |
| EP-0031473-A1 | Process for preparing 2-((alkoxycarbonyl)-amino)-5-(alkylthio)-1H-benzimidazoles | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1981-07-08 | — | — | EP | disclosed |
| US-3940416-A | PARASITICIDES | FISONS LTD. (EN) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140171363-A1 | BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF | ACACA, ACACB, COASY | ALDH3A1 198/4885HTT 2987/4885POLB 1792/4885 |
| US-20120028969-A1 | BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF | ACACA, ACACB, COASY | ALDH3A1 198/4885HTT 2987/4885POLB 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.